Future studies on the complete elucidation of the Mecp2 alternative splicing mechanism may open up the way to find therapeutic approaches for particular Rett syndrome patients with high expression levels of MeCP2 protein. This evidence concerns the gene MECP2 and atypical Rett syndrome.